Rezolute Inc [RZLT] - Last Close: $3.68
Shares of Rezolute are soaring on an upbeat clinical data release.
The clinical-stage biopharmaceutical firm announced positive data from Phase 2b RIZE study of RZ358.
The study demonstrated that the drug was safe and tolerable in patients with congenital hyperinsulinism, and it also produced "highly significant" improvements in hypoglycemia.
The RIZE study results will be presented in an oral presentation at an upcoming medical congress in 2Q 2022, followed by a conference call hosted by the Company to discuss the data.
RZLT is one of the most active premarket stocks, and it's up 38.3%
Creative Realities [CREX] - Last Close: $0.858
Creative Realities is trending on the heels of a strong quarter.
The digital marketing firm's fourth-quarter results showed revenues grew 8.3% YoY to $5.4 million and beat the consensus estimates of $4.99 million.
Creative Realities also earned a net income of $0.20 million in fiscal 2021, after the company ended the previous year with a net loss of $16.8 million.
During Q4, the company won a significant new theme park customer who will continue to deploy the hardware.
CREX expects to add more than 1,300 billable devices, generating monthly recurring subscription revenue to content management software platforms.
The company expects 2022 revenues to exceed $43 million.
CREX is trading actively with a 35.2% gain.
